Literature DB >> 10593153

Salivary gland neoplasms: a descriptive analysis of the pattern seen in Enugu.

B C Ezeanolue1.   

Abstract

The objective of this study is to describe the pattern of salivary gland neoplasms as experienced in Enugu-Nigeria. Patients are selected from those attending the Otorhinolaryngology units of the author at the University of Nigeria Teaching Hospital and Balsam Clinics both in Enugu from January 1992 to December 1997, with tumours of salivary gland origin. Non-neoplastic lesions were excluded. There were forty-one (41) patients with salivary gland neoplastic growths in the following sites: parotids (25) submandibular gland (SMG) (10) and minor (6). There were 15 males, 26 females; age range 10-74 year, with mean of 41 years. Seven of the parotid tumours were recurrent/residual. Salivary gland neoplasms are important surgical disease in this region with clinical manifestations similar to what obtains in other parts of the world. Surgical excision of salivary neoplasms is beneficial, but misadventure is still rampant.

Entities:  

Mesh:

Year:  1999        PMID: 10593153

Source DB:  PubMed          Journal:  West Afr J Med        ISSN: 0189-160X


  4 in total

1.  Salivary gland tumors in Uganda: clinical pathological study.

Authors:  Edda A M Vuhahula
Journal:  Afr Health Sci       Date:  2004-04       Impact factor: 0.927

2.  Pattern of salivary gland tumors in Manipur, India: A 10 year study.

Authors:  Rajesh Singh Laishram; K Arun Kumar; Gayatri Devi Pukhrambam; Sharmila Laishram; Kaushik Debnath
Journal:  South Asian J Cancer       Date:  2013-10

3.  Utility of smooth muscle actin and CD117 as reliable markers in the diagnosis of salivary gland neoplasms.

Authors:  Subhasri Raman; Herald J Sherlin
Journal:  J Oral Maxillofac Pathol       Date:  2019 May-Aug

Review 4.  Current evidence on the burden of head and neck cancers in Nigeria.

Authors:  Opubo B da Lilly-Tariah; Abayomi O Somefun; Wasiu L Adeyemo
Journal:  Head Neck Oncol       Date:  2009-05-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.